Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the ...
As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果